Accessibility Menu
 
BlackRock Science And Technology Term Trust logo

BlackRock Science And Technology Term Trust

(NYSE) BSTZ

Current Price$22.62
Market Cap$1.56B
Since IPO (2019)+109%
5 Year+4%
1 Year+44%
1 Month-2%

BlackRock Science And Technology Term Trust Financials at a Glance

Market Cap

$1.56B

Revenue (TTM)

$361.49M

Net Income (TTM)

$586.64M

EPS (TTM)

$4.57

P/E Ratio

4.84

Dividend

$2.64

Beta (Volatility)

1.23 (Average)

Price

$22.62

Volume

5,808

Open

$22.31

Previous Close

$22.62

Daily Range

$22.31 - $22.81

52-Week Range

$15.22 - $23.47

BSTZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BlackRock Science And Technology Term Trust

Industry

Capital Markets

CEO

John M. Perlowski

Headquarters

New York City, NY 10055, US

BSTZ Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

1%

Net Income Margin

1%

Return on Equity

19%

Return on Capital

17%

Return on Assets

17%

Earnings Yield

20.66%

Dividend Yield

0.12%

Payout Ratio

57.19%

Stock Overview

Market Cap

$1.56B

Shares Outstanding

70.51M

Volume

5.81K

Short Interest

0.00%

Avg. Volume

251.41K

Financials (TTM)

Gross Profit

$245.38M

Operating Income

$314.79M

EBITDA

$314.36M

Operating Cash Flow

$47.75M

Capital Expenditure

$5.00

Free Cash Flow

$47.75M

Cash & ST Invst.

$30.35M

Total Debt

$17.50M

BlackRock Science And Technology Term Trust Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$140.57M

+94.5%

Gross Profit

$129.62M

+95.3%

Gross Margin

92.21%

N/A

Market Cap

$1.56B

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$286.52M

+297.3%

EBITDA

$286.52M

+297.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$12.84M

+267.3%

Accounts Receivable

$1.56M

-25.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$17.50M

+444.8%

Return on Assets

16.85%

N/A

Return on Invested Capital

16.84%

N/A

Free Cash Flow

$33.33M

-342.9%

Operating Cash Flow

$33.33M

-342.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDJBlackRock Enhanced Equity Dividend Trust
$8.75+1.51%
FZADXFidelity Advisor Dividend Growth Z
$25.41+0.75%
BCATBlackRock Capital Allocation Trust
$14.36+1.63%
FSTRXFederated Hermes MDT Large Cap Value Fund Class A
$34.98+2.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%

Questions About BSTZ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.